Next Day Disclosure Return
Filed with HKEX · Stock code 3696 · · 7 pages · English
InSilico Medicine Cayman TopCo on 6ix
Earlier from InSilico Medicine Cayman TopCo
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Discloseable transaction participation in the establishment of an investment fund
- Voluntary announcement on-market share repurchase
- Grant of restricted share units
- Voluntary announcement InSilico Medicine reports preliminary positive first-in-human clinical trial data for ISM6331 designed using generative AI in mesothelioma and other solid tumors at esmo 2026
Later from InSilico Medicine Cayman TopCo
- Voluntary announcement InSilico Medicine and luoxin pharmaceuticals enter into strategic collaboration on AI-powered drug discovery for digestive, metabolic and other chronic diseases
- Voluntary announcement InSilico Medicine completes first-in-human dosing in exploratory trial of AI-driven non-opioid pain candidate ISM9528
Follow InSilico Medicine Cayman TopCo into a list and get an email when it puts out news.
Follow InSilico Medicine Cayman TopCo